78868 Federal Register / Vol. 85, No. 235 / Monday, December 7, 2020 / Notices 

description under the above HTS 

subheading. 

Section 202(d)(1)(C) of the Trade Act 

provides procedures under which 

domestic producers of a perishable 

agricultural product may, in a petition 

filed under section 202(a) of the Trade 

Act, request provisional relief. Under 

those procedures, if the Commission has 

monitored imports of the article for at 

least 90 days, the domestic industry 

may, in such a petition, request a 

preliminary determination and 

provisional relief pending completion of 

a full Commission investigation. Should 

that occur, the Commission would have 

21 days, from the day on which the 

request was received, to make a 

preliminary injury determination, and if 

in the affirmative, to recommend 

provisional relief to the President. 

Public Hearing: No public hearing is 

planned at this time in connection with 

this investigation. However, should a 

public hearing or conference be 

scheduled, the Commission will publish 

a notice in the Federal Register and post 

information about the hearing on the 

Commission’s website at (https://

usitc.gov/research_and_analysis/what_

we_are_working_on.htm). Once on that 

web page, scroll down to the entry for 

Investigation No. 332–581, Monitoring 

of Fresh or Chilled Strawberries, and 

click on the link to ‘‘hearing 

instructions.’’ 

Written Submissions: Interested 

parties are invited to file written 

submissions concerning this 

investigation. The Commission is 

particularly interested in receiving 

information about imports, principal 

source countries, and impact of the 

imports on the domestic industry 

producing the like or directly 

competitive product. The Commission 

is also interested in receiving 

information about the condition of the 

domestic industry, including with 

respect to production, employment, 

profits and losses, and other factors set 

out in section 202(c) of the Trade Act. 

To the extent practical, data and 

information should include the period 

2016–2020 and any subsequent period. 

All written submissions should be 

addressed to the Secretary, and should 

be received not later than 5:15 p.m., 

January 15, 2021. All written 

submissions must conform to the 

provisions of section 201.8 of the 

Commission’s Rules of Practice and 

Procedure (19 CFR 201.8), as 

temporarily amended by 85 FR 15798 

(March 19, 2020). 

Under that rule waiver, the Office of 

the Secretary will accept only electronic 

filings at this time. Filings must be 

made through the Commission’s 

Electronic Document Information 

System (EDIS, https://edis.usitc.gov). No 

in-person paper-based filings or paper 

copies of any electronic filings will be 

accepted until further notice. Persons 

with questions regarding electronic 

filing should contact the Office of the 

Secretary, Docket Services Division 

(202–205–1802), or consult the 

Commission’s Handbook on Filing 

Procedures. 

Confidential Business Information. 

Any submissions that contain 

confidential business information (CBI) 

must also conform to the requirements 

of section 201.6 of the Commission’s 

Rules of Practice and Procedure (19 CFR 

201.6). Section 201.6 of the rules 

requires that the cover of the document 

and the individual pages be clearly 

marked as to whether they are the 

‘‘confidential’’ or ‘‘non- confidential’’ 

version, and that the confidential 

business information is clearly 

identified by means of brackets. All 

written submissions, except for 

confidential business information, will 

be made available for inspection by 

interested parties. 

Limited Disclosure of CBI. Should a 

petition be filed under section 202(a) of 

the Trade Act and an investigation be 

instituted under section 202(b) of the 

Trade Act with respect to the products 

covered by this investigation, the 

Secretary will make some or all of the 

CBI obtained in this monitoring 

investigation available, pursuant to 

§ 206.17 of the Commission’s rules, to 

authorized applicants under an 

administrative protective order (APO) 

issued in that investigation in 

accordance with the procedures set 

forth in section 206.17 of the rules. 

The Commission may also include 

some or all CBI submitted in this 

investigation in the report it sends to the 

President and the U.S. Trade 

Representative in an investigation 

conducted under section 202(b) or in a 

related investigation. The Commission 

will not otherwise disclose information 

which it considers to be CBI unless the 

party submitting the information had 

notice, at the time of submission, that 

such information would be released by 

the Commission, or such party 

subsequently consents to the release of 

the information. See 19 U.S.C. 

2252(a)(8) and 19 U.S.C. 1332(g). 

Authority: This investigation is being 

conducted under authority of section 

202(d)(1)(B) of the Trade Act and section 

332(g) of the Tariff Act of 1930. 

By order of the Commission. 

Issued: December 2, 2020. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2020–26857 Filed 12–4–20; 8:45 am] 

BILLING CODE 7020–02–P 

INTERNATIONAL TRADE 

COMMISSION 

Notice of Receipt of Complaint; 

Solicitation of Comments Relating to 

the Public Interest 

AGENCY: International Trade 

Commission. 

ACTION: Notice. 

SUMMARY: Notice is hereby given that 

the U.S. International Trade 

Commission has received a complaint 

entitled Certain Gabapentin 

Immunoassay Kits and Test Strips, 

Components Thereof, and Methods 

Therefor, DN 3511; the Commission is 

soliciting comments on any public 

interest issues raised by the complaint 

or complainant’s filing pursuant to the 

Commission’s Rules of Practice and 

Procedure. 

FOR FURTHER INFORMATION CONTACT: Lisa 

R. Barton, Secretary to the Commission, 

U.S. International Trade Commission, 

500 E Street SW, Washington, DC 

20436, telephone (202) 205–2000. The 

public version of the complaint can be 

accessed on the Commission’s 

Electronic Document Information 

System (EDIS) at https://edis.usitc.gov. 

For help accessing EDIS, please email 

EDIS3Help@usitc.gov. 

General information concerning the 

Commission may also be obtained by 

accessing its internet server at United 

States International Trade Commission 

(USITC) at https://www.usitc.gov. The 

public record for this investigation may 

be viewed on the Commission’s 

Electronic Document Information 

System (EDIS) at https://edis.usitc.gov. 

Hearing-impaired persons are advised 

that information on this matter can be 

obtained by contacting the 

Commission’s TDD terminal on (202) 

205–1810. 

SUPPLEMENTARY INFORMATION: The 

Commission has received a complaint 

and a submission pursuant to § 210.8(b) 

of the Commission’s Rules of Practice 

and Procedure filed on behalf of ARK 

Diagnostics, Inc. on December 2, 2020. 

The complaint alleges violations of 

section 337 of the Tariff Act of 1930 (19 

U.S.C. 1337) in the importation into the 

United States, the sale for importation, 

and the sale within the United States 

after importation of certain gabapentin 

immunoassay kits and test strips, 

components thereof, and methods 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 85, No. 235 / Monday, December 7, 2020 / Notices 78869 

1Handbook for Electronic Filing Procedures: 

https://www.usitc.gov/documents/handbook_on_

filing_procedures.pdf. 

2All contract personnel will sign appropriate 

nondisclosure agreements. 

3Electronic Document Information System 

(EDIS): https://edis.usitc.gov. 

therefor. The complaint names as 

respondents: Hangzhou AllTest Biotech 

Co., Ltd. of China; Shanghai Chemtron 

Biotech Co., Ltd. of China; Chemtron 

Biotech Co., Ltd of San Diego, CA; 

Zhejiang Orient Gene Biotech Co., Ltd. 

of China; Healgen Scientific, LLC of 

Houston, TX; Kappa City Biotech, SAS 

of France; 12PanelMedical, Inc. of 

Sarasota, FL; Acro Biotech, Inc. of 

Rancho Cucamonga, CA; AlcoPro, Inc. 

of Knoxville, TN; American Screening, 

LLC of Shreveport, LA; Confirm 

Biosciences, Inc. of San Diego, CA; 

Mercedes Medical, LLC of Lakewood 

Ranch, FL; TransMed Co., LLC of 

Alpharetta, GA; and Transmetron, Inc. 

of Salt Lake City, UT. The complainant 

requests that the Commission issue a 

limited exclusion order, cease and 

desist orders and impose a bond upon 

respondents’ alleged infringing articles 

during the 60-day Presidential review 

period pursuant to 19 U.S.C. 1337(j). 

Proposed respondents, other 

interested parties, and members of the 

public are invited to file comments on 

any public interest issues raised by the 

complaint or § 210.8(b) filing. 

Comments should address whether 

issuance of the relief specifically 

requested by the complainant in this 

investigation would affect the public 

health and welfare in the United States, 

competitive conditions in the United 

States economy, the production of like 

or directly competitive articles in the 

United States, or United States 

consumers. 

In particular, the Commission is 

interested in comments that: 

(i) Explain how the articles 

potentially subject to the requested 

remedial orders are used in the United 

States; 

(ii) identify any public health, safety, 

or welfare concerns in the United States 

relating to the requested remedial 

orders; 

(iii) identify like or directly 

competitive articles that complainant, 

its licensees, or third parties make in the 

United States which could replace the 

subject articles if they were to be 

excluded; 

(iv) indicate whether complainant, 

complainant’s licensees, and/or third 

party suppliers have the capacity to 

replace the volume of articles 

potentially subject to the requested 

exclusion order and/or a cease and 

desist order within a commercially 

reasonable time; and 

(v) explain how the requested 

remedial orders would impact United 

States consumers. 

Written submissions on the public 

interest must be filed no later than by 

close of business, eight calendar days 

after the date of publication of this 

notice in the Federal Register. There 

will be further opportunities for 

comment on the public interest after the 

issuance of any final initial 

determination in this investigation. Any 

written submissions on other issues 

must also be filed by no later than the 

close of business, eight calendar days 

after publication of this notice in the 

Federal Register. Complainant may file 

replies to any written submissions no 

later than three calendar days after the 

date on which any initial submissions 

were due. Any submissions and replies 

filed in response to this Notice are 

limited to five (5) pages in length, 

inclusive of attachments. 

Persons filing written submissions 

must file the original document 

electronically on or before the deadlines 

stated above. Submissions should refer 

to the docket number (‘‘Docket No. 

3511’’) in a prominent place on the 

cover page and/or the first page. (See 

Handbook for Electronic Filing 

Procedures, Electronic Filing 

Procedures 1). Please note the 

Secretary’s Office will accept only 

electronic filings during this time. 

Filings must be made through the 

Commission’s Electronic Document 

Information System (EDIS, https://

edis.usitc.gov.) No in-person paperbased filings or paper copies of any 

electronic filings will be accepted until 

further notice. Persons with questions 

regarding filing should contact the 

Secretary at EDIS3Help@usitc.gov. 

Any person desiring to submit a 

document to the Commission in 

confidence must request confidential 

treatment. All such requests should be 

directed to the Secretary to the 

Commission and must include a full 

statement of the reasons why the 

Commission should grant such 

treatment. See 19 CFR 201.6. Documents 

for which confidential treatment by the 

Commission is properly sought will be 

treated accordingly. All information, 

including confidential business 

information and documents for which 

confidential treatment is properly 

sought, submitted to the Commission for 

purposes of this Investigation may be 

disclosed to and used: (i) By the 

Commission, its employees and Offices, 

and contract personnel (a) for 

developing or maintaining the records 

of this or a related proceeding, or (b) in 

internal investigations, audits, reviews, 

and evaluations relating to the 

programs, personnel, and operations of 

the Commission including under 5 

U.S.C. Appendix 3; or (ii) by U.S. 

government employees and contract 

personnel,2 solely for cybersecurity 

purposes. All nonconfidential written 

submissions will be available for public 

inspection at the Office of the Secretary 

and on EDIS.3

This action is taken under the 

authority of section 337 of the Tariff Act 

of 1930, as amended (19 U.S.C. 1337), 

and of §§ 201.10 and 210.8(c) of the 

Commission’s Rules of Practice and 

Procedure (19 CFR 201.10, 210.8(c)). 

By order of the Commission. 

Issued: December 2, 2020. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2020–26861 Filed 12–4–20; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

Antitrust Division 

Notice Pursuant to the Defense 

Production Act of 1950 

AGENCY: Antitrust Division, U.S. 

Department of Justice. 

ACTION: Notice of review of plan of 

action. 

SUMMARY: Notice is hereby given 

pursuant to section 708 of the Defense 

Production Act of 1950 (‘‘DPA’’), that 

the Assistant Attorney General finds, 

with respect to the Plan of Action to 

Establish a National Strategy for the 

Manufacture, Allocation and 

Distribution of Personal Protective 

Equipment (PPE) to Respond to COVID– 

19 (‘‘Plan of Action’’) proposed by the 

Federal Emergency Management Agency 

(‘‘FEMA’’), that the purposes of section 

708(c)(1) of the DPA may not reasonably 

be achieved through a plan of action 

having less anticompetitive effects or 

without any plan of action. Given this 

finding, the proposed Plan of Action 

may become effective following the 

publication of this notice. 

SUPPLEMENTARY INFORMATION: Under the 

DPA, FEMA may enter into plans with 

representatives of private industry for 

the purpose of improving the efficiency 

with which private firms contribute to 

the national defense when conditions 

exist that may pose a direct threat to the 

national defense or its preparedness. 

Such arrangements are generally known 

as ‘‘voluntary agreements.’’ Participants 

in an existing voluntary agreement may 

adopt documented methods, known as 


khammond on DSKJM1Z7X2PROD with NOTICES